These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24352201)

  • 21. Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?
    Ha YC; Cho MR; Park KH; Kim SY; Koo KH
    Clin Orthop Relat Res; 2010 Dec; 468(12):3393-8. PubMed ID: 20865463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilateral femur fractures associated with short-term bisphosphonate use.
    Rifai A; Pourtaheri S; Carbone A; Callaghan JJ; Stadler CM; Record N; Issa K
    Orthopedics; 2015 Feb; 38(2):e139-42. PubMed ID: 25665120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years.
    Lo JC; Neugebauer RS; Ettinger B; Chandra M; Hui RL; Ott SM; Grimsrud CD; Izano MA
    BMC Musculoskelet Disord; 2020 Dec; 21(1):801. PubMed ID: 33272248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years.
    Haschka J; Kühne F; Muschitz C; Pirker T; Kocijan R; Bittighofer C; Trubrich A; Resch H
    Wien Klin Wochenschr; 2011 Nov; 123(21-22):684-7. PubMed ID: 21837437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis-a case report.
    Piponov HI; Goldstein JM; Eisenberg GM
    Osteoporos Int; 2020 Nov; 31(11):2263-2267. PubMed ID: 32561954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonates and the risk of atypical femur fractures.
    Black DM; Condra K; Adams AL; Eastell R
    Bone; 2022 Mar; 156():116297. PubMed ID: 34920168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of atypical femoral fracture: a scoping review and comprehensive algorithm.
    Toro G; Ojeda-Thies C; Calabrò G; Toro G; Moretti A; Guerra GM; Caba-Doussoux P; Iolascon G
    BMC Musculoskelet Disord; 2016 May; 17():227. PubMed ID: 27215972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Bögl HP; Aspenberg P; Schilcher J
    Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATYPICAL FEMORAL FRACTURES AFTER LONG-TERM BISPHOSPHONATES THERAPY: CASE REPORT.
    Găleşanu C; Mocanu V; Buzdugă C; Florescu A; Zaharia V; Lisnic V
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):114-8. PubMed ID: 27125082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis.
    Wong CH; Kan AKC; Tsoi KH; Chan SSY; Jiang NS; Loong CHN; Fong CHY; Wong JSH; Shea GKH; Cheung CL; Lee CH; Tan KCB; Woo YC; Lui DTW
    Endocrine; 2024 Apr; 84(1):223-235. PubMed ID: 37985574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical Femoral Fractures (AFF) from Bone Remodeling Agents in Patients with Cancer.
    Kordoni M; Rigakos G; Kim YHM; Kaklamanis L; Nikolatou-Galitis O; Hadjiyassemi L; Labropoulos S; Razis E
    Anticancer Res; 2018 Nov; 38(11):6439-6444. PubMed ID: 30396969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.
    Adams AL; Xue F; Chantra JQ; Dell RM; Ott SM; Silverman S; Giaconi JC; Critchlow C
    Osteoporos Int; 2017 Jan; 28(1):413-417. PubMed ID: 27766369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.
    Isaacs JD; Shidiak L; Harris IA; Szomor ZL
    Clin Orthop Relat Res; 2010 Dec; 468(12):3384-92. PubMed ID: 20809164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy.
    Gu KD; Ettinger B; Grimsrud CD; Lo JC
    Osteoporos Int; 2021 Oct; 32(10):2119-2123. PubMed ID: 33914104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication management after intramedullary nailing of atypical fractures.
    Feron JM; Cambon-Binder A
    Injury; 2017 Jun; 48 Suppl 1():S15-S17. PubMed ID: 28456365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures.
    Banffy MB; Vrahas MS; Ready JE; Abraham JA
    Clin Orthop Relat Res; 2011 Jul; 469(7):2028-34. PubMed ID: 21350886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonate-related femoral periosteal stress reactions: scoring system based on radiographic and MRI findings.
    Png MA; Koh JS; Goh SK; Fook-Chong S; Howe TS
    AJR Am J Roentgenol; 2012 Apr; 198(4):869-77. PubMed ID: 22451554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do bisphosphonates cause femoral insufficiency fractures?
    Seraphim A; Al-Hadithy N; Mordecai SC; Al-Nammari S
    J Orthop Traumatol; 2012 Dec; 13(4):171-7. PubMed ID: 22850908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonate-associated fractures of the femur: pathophysiology and treatment.
    Einhorn TA; Bogdan Y; Tornetta P
    J Orthop Trauma; 2014 Jul; 28(7):433-8. PubMed ID: 24121986
    [No Abstract]   [Full Text] [Related]  

  • 40. Conservative treatment of recurrent symptoms of an incomplete, atypical femoral fracture associated with glucocorticoid, bisphosphonate, and denosumab therapy in a patient with chronic obstructive pulmonary disease.
    Lai KH; Chiang CY; Yang RS; Yang KC; Wu CC
    Acta Clin Belg; 2019 Oct; 74(5):370-374. PubMed ID: 30336748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.